Drug Genetic Disease

Elevidys

Payments companies reported to CMS as associated with Elevidys. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$1.1Massociated payments (2023-2025)
305clinicians with associated payments
1company reporting

By year

2023 $2,358
2024 $376K
2025 $679K

Payments reported as associated with Elevidys, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Neurology With Special Qualifications In Child Neurology $613K
Neuromuscular Medicine (Psychiatry & Neurology) $105K
Neurology (Psychiatry & Neurology) $70K
Pediatrics $57K
Physical Medicine & Rehabilitation $54K
Neurodevelopmental Disabilities (Pediatrics) $30K

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Elevidys

These are the largest totals companies reported as associated with Elevidys. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Erika Finanger Portland, OR Neurology With Special Qualifications In Child Neurology $53,560.57
Sarah Wright Washington, DC Neurology With Special Qualifications In Child Neurology $40,400.84
Omer Abdul Hamid Orlando, FL Neurology With Special Qualifications In Child Neurology $35,631.50
Kathryn Mosher Akron, OH Physical Medicine & Rehabilitation $34,655.98
Alexander Fay Saint Louis, MO Pediatrics $31,881.69
Daniel Guillen Mendoza Memphis, TN Neuromuscular Medicine (Psychiatry & Neurology) $26,772.34
Randal Richardson Saint Paul, MN Neurology With Special Qualifications In Child Neurology $25,960.86
Hoda Abdel Hamid Pittsburgh, PA Pediatrics $24,252.02
Cuixia Tian Cincinnati, OH Neurology With Special Qualifications In Child Neurology $23,834.95
Mary Lynn Chu New York, NY Neurology With Special Qualifications In Child Neurology $23,701.65

Prescribed Elevidys?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.